Griseofulvin

🧮 Dose calculator

Fungal skin infection (tinea, cutaneous candida) · Regimen source: FDA Griseofulvin susp · Dosage and Administration

• • Or 125 mg four times or 250 mg twice daily. Widespread lesions: start 0.75–1 g/day. Duration: tinea capitis 4–6 weeks, corporis 2–4 weeks, pedis 4–8 weeks. FDA Griseofulvin susp · Dosage and Administration

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyContraindicated

  Label: contraindicated in pregnancy. FDA Griseofulvin susp · CONTRAINDICATIONS

  “Two published cases of conjoined twins have been reported in patients taking griseofulvin during the first trimester of pregnancy, therefore, griseofulvin is contraindicated in women who are or may become pregnant during treatment.”

• 🤱 BreastfeedingDangerous / avoid

  Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Griseofulvin susp · Nursing Mothers:

  “… y shown for griseofulvin in animal studies (see PRECAUTIONS , Carcinogenesis, Mutagenesis, Impairment of Fertility ), a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.”

• 👶 ChildrenSafety not established

  Label: safety and effectiveness in children have not been established. FDA Griseofulvin susp · Pediatric Use:

  “Safety and effectiveness in pediatric patients 2 years of age and younger have not been established.”

• 👴 Older adultsNo data

  The source for this drug has no section for this group.

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.